Actuate Therapeutics (ACTU) Current Assets (2023 - 2025)
Actuate Therapeutics (ACTU) posted quarterly Current Assets of $13.6 million for Q4 2025, up 48.17% year-over-year from $9.2 million in Q4 2024, and down 21.79% quarter-over-quarter from $17.4 million in Q3 2025.
Actuate Therapeutics (ACTU) Current Assets (2023 - 2025) Analysis & Trends
Actuate Therapeutics (ACTU) has reported Current Assets for 3 consecutive years, with $13.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Assets rose 48.17% year-over-year to $13.6 million; the TTM figure through Dec 2025 stood at $13.6 million (up 48.17% YoY), while the FY2025 annual figure was $13.6 million, up 48.17% from the prior year.
- Current Assets slipped to $13.6 million in Q4 2025 per ACTU's latest filing, from $17.4 million in the prior quarter.
- Across five years, Current Assets topped out at $17.4 million in Q3 2025 and bottomed at $549687.0 in Q2 2024.
- Historically, Current Assets has averaged $8.6 million across 3 years, with a median of $7.9 million in 2024.
- On a YoY basis, Current Assets climbed as much as 1116.79% in 2025 and fell as far as 22.3% in 2025.
- Actuate Therapeutics' Current Assets stood at $3.0 million in 2023, then soared by 207.38% to $9.2 million in 2024, then surged by 48.17% to $13.6 million in 2025.
- Business Quant data shows ACTU's Current Assets at $13.6 million in Q4 2025, $17.4 million in Q3 2025, and $6.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | Actuate Therapeutics | 30.08 Mn | 30.08 Mn | - | 4.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.64 Mn |
| Sep 30, 2025 | 17.44 Mn |
| Jun 30, 2025 | 6.69 Mn |
| Mar 31, 2025 | 4.25 Mn |
| Dec 31, 2024 | 9.21 Mn |
| Sep 30, 2024 | 14.26 Mn |
| Jun 30, 2024 | 549,687.00 |
| Dec 31, 2023 | 3.00 Mn |